Daewoong Pharmaceutical Co. LTD.
The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.
- Drug: DWJ1252DWJ1252 and Placebo of Gasmotin
- Drug: GasmotinGasmotin and Placebo of DWJ1252
|Ages eligible for Study||19 Years and older|
|Genders eligible for Study||All|
|Accepts Healthy Volunteers||No|
- Male of female of at least 19 years old
- Patient with functional dyspepsia met the ROME III criteria
- Patients with previous gastrointestinal surgery
- Patients with history of gastrointestinal bleeding, mechanical obstruction, perforation
- Patients with history of gastrointestinal cancer
Korea, Republic of (1)
- Hanyang University Medical CenterrecruitingSeoul, Korea, Republic of
30 November, 2016
14 January, 2017